135 related articles for article (PubMed ID: 6440414)
41. Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis.
Kappler M; Kraxner A; Reinhardt D; Ganster B; Griese M; Lang T
Thorax; 2006 Aug; 61(8):684-8. PubMed ID: 16449259
[TBL] [Abstract][Full Text] [Related]
42. Direct sputum analysis of Pseudomonas aeruginosa macrorestriction fragment genotypes in patients with cystic fibrosis.
Breitenstein S; Walter S; Bosshammer J; Römling U; Tümmler B
Med Microbiol Immunol; 1997 Oct; 186(2-3):93-9. PubMed ID: 9403836
[TBL] [Abstract][Full Text] [Related]
43. Antibody response of rabbits and cystic fibrosis patients to an alginate-specific outer membrane protein of a mucoid strain of Pseudomonas aeruginosa.
Rehm BH; Grabert E; Hein J; Winkler UK
Microb Pathog; 1994 Jan; 16(1):43-51. PubMed ID: 8057826
[TBL] [Abstract][Full Text] [Related]
44. Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.
Mauch RM; Rossi CL; Nolasco da Silva MT; Bianchi Aiello T; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Med Microbiol Immunol; 2019 Apr; 208(2):205-213. PubMed ID: 30706137
[TBL] [Abstract][Full Text] [Related]
45. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis.
Hancock RE; Mouat EC; Speert DP
J Infect Dis; 1984 Feb; 149(2):220-6. PubMed ID: 6421943
[TBL] [Abstract][Full Text] [Related]
46. Genotyping of Pseudomonas aeruginosa sputum and stool isolates from cystic fibrosis patients: evidence for intestinal colonization and spreading into toilets.
Döring G; Bareth H; Gairing A; Wolz C; Botzenhart K
Epidemiol Infect; 1989 Dec; 103(3):555-64. PubMed ID: 2514111
[TBL] [Abstract][Full Text] [Related]
47. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.
Van Bever HP; Gigase PL; De Clerck LS; Bridts CH; Franckx H; Stevens WJ
Arch Dis Child; 1988 Oct; 63(10):1222-8. PubMed ID: 3143315
[TBL] [Abstract][Full Text] [Related]
48. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.
Pier GB
J Infect Dis; 1985 Apr; 151(4):575-80. PubMed ID: 3919113
[No Abstract] [Full Text] [Related]
49. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.
Petersen TD; Ciofu O; Pressler T; Giwercman B; Pedersen SS; Høiby N
Thorax; 1996 Jul; 51(7):733-8. PubMed ID: 8882082
[TBL] [Abstract][Full Text] [Related]
50. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection.
Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
Pediatr Pulmonol; 1992 Sep; 14(1):44-51. PubMed ID: 1437343
[TBL] [Abstract][Full Text] [Related]
51. Epidemiology and clinical impact of Pseudomonas aeruginosa infection in cystic fibrosis using AP-PCR fingerprinting.
Adams C; Morris-Quinn M; McConnell F; West J; Lucey B; Shortt C; Cryan B; Watson JB; O'Gara F
J Infect; 1998 Sep; 37(2):151-8. PubMed ID: 9821090
[TBL] [Abstract][Full Text] [Related]
52. Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.
Tingpej P; Smith L; Rose B; Zhu H; Conibear T; Al Nassafi K; Manos J; Elkins M; Bye P; Willcox M; Bell S; Wainwright C; Harbour C
J Clin Microbiol; 2007 Jun; 45(6):1697-704. PubMed ID: 17392437
[TBL] [Abstract][Full Text] [Related]
53. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
Winkler U; Wingender J; Jäger KE
Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
[TBL] [Abstract][Full Text] [Related]
54. Circulating immune complexes in cystic fibrosis.
Berdischewsky M; Pollack M; Young LS; Chia D; Osher AB; Barnett EV
Pediatr Res; 1980 Jun; 14(6):830-3. PubMed ID: 6773019
[TBL] [Abstract][Full Text] [Related]
55. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
[TBL] [Abstract][Full Text] [Related]
56. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR
J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977
[TBL] [Abstract][Full Text] [Related]
57. Circulating immune complexes in cystic fibrosis.
Manthei U; Taussig LM; Beckerman RC; Strunk RC
Am Rev Respir Dis; 1982 Aug; 126(2):253-7. PubMed ID: 7103251
[TBL] [Abstract][Full Text] [Related]
58. Extracellular toxins of Pseudomonas aeruginosa. IV. Radioimmunoassay for detection of elastase.
Obernesser HJ; Döring G
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):248-56. PubMed ID: 6812322
[TBL] [Abstract][Full Text] [Related]
59. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
60. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
Hornick DB; Fick RB
J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
